Achieve Life Sciences

ACHV · NASDAQ

$6.51−$0.095 (−1.44%)TodayMarket closed ·
Prev close $6.60

Latest news

  • Press releaseGlobe Newswire

    Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications

  • Press releaseGlobe Newswire

    Achieve Life Sciences Announces Granting of New Hire Inducement Awards

  • Press releaseGlobe Newswire

    Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer

  • Press releaseGlobe Newswire

    Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

  • Press releaseGlobe Newswire

    Achieve Life Sciences Announced Granting of New Hire Inducement Awards

  • Press releaseGlobe Newswire

    Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

  • Press releaseGlobe Newswire

    Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

  • Press releaseGlobe Newswire

    Achieve Life Sciences Announced Granting of New Hire Inducement Awards

  • NewsAvi Kapoor

    Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

  • Press releaseGlobe Newswire

    Achieve Life Sciences Joins Russell 2000® Index

  • NewsVandana Singh

    FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned

  • NewsRishabh Mishra

    SPCX, INTC, NFLX And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

  • Press releaseGlobe Newswire

    Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

  • News

    Achieve Life Sciences Reports Q1 2026 Results: Full Earnings Call Transcript

  • News

    Earnings Scheduled For May 12, 2026

  • Press releaseGlobe Newswire

    Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates

  • Press releaseGlobe Newswire

    Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsVandana Singh

    Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    Earnings Scheduled For March 24, 2026

  • Press releaseGlobe Newswire

    Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

  • NewsVandana Singh

    New Report Calls Achieve Life's Cytisinicline Best Therapy To Quit Smoking

  • Press releasePRNewswire

    Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

  • News

    Earnings Scheduled For November 6, 2025

  • NewsVandana Singh

    FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

  • NewsVandana Singh

    Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

  • News

    What to Expect from Achieve Life Sciences's Earnings

  • NewsAvi Kapoor

    This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

  • Press releaseGlobe Newswire

    Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.